Insight & Intelligence™ : Jul 31, 2012
Top Paid Women in Biopharma
GEN’s listing of the 25 highest-paid females in the industry.
- Alex Philippidis
#25. Paula J. Swain
EVP, Human resources, Incyte
2011 Compensation: $1,309,024
#24. Patricia S. Andrews
EVP and Chief Commercial Officer, Incyte
2011 Compensation: $1,336,538
#23. Mary Sontrop
EVP, Operation, CSL
2011 Compensation: $1,403,020 (A$1,337,883)
#22. B. Lynne Parshall
Director, COO, CFO, Isis Pharmaceuticals
2011 Compensation: $1,434,819
#21. Marcea Bland Lloyd
SVP, Chief Administrative Officer and General Counsel, Amylin Pharmaceuticals
2011 Compensation: $1,615,038
#20. Jane Wasman
Chief, Strategic Development, General Counsel and Corporate secretary, Acorda Therapeutics
2011 Compensation: $1,645,473
#19. Elizabeth B. Rae
VP, Human Resources, Waters
2011 Compensation: $1,663,179
#18. Tamara Joseph
SVP, General Counsel and Secretary, Cubist Pharmaceuticals
2011 Compensation: $2,151,232
#17. Deborah L. Tanner
Corporate EVP and Group President, Research and Development Laboratories, Covance
2011 Compensation: $2,419,761
#16. Jacqualyn A. Fouse
EVP and CFO, Celgene
2011 Compensation: $2,535,033
#15. Lynn Seely, M.D.
CMO, Medivation
2011 Compensation: $2,579,028
#14. Martine A. Rothblatt, Ph.D
Chairman and CEO, United Therapeutics
2011 Compensation: $3,161,350
#13. Helen Torley, M.B., Ch.B
EVP and CCO, Onyx Pharmaceuticals
2011 Compensation: $3,346,433
#12. Nancy J. Wysenski
EVP and CCO, Vertex Pharmaceuticals
2011 Compensation: $3,352,768
#11. Cheryl Cohen
CCO, Medivation
2011 Compensation: $3,554,519
#10. Robin Smith
CEO, NeoStem
2011 Compensation: $3,647,772
#9. Robin L. Washington
SVP and CFO, Gilead Sciences
2011 Compensation: $4,032,193
#8. Silvia Ayyoubi
Head of Human Resources, Roche
2011 Compensation: $4,035,692
#7. Sandra Leung
General Counsel and Secretary, Bristol-Myers Squibb
2011 Compensation: $5,491,673
#6. Laura J. Schumacher
EVP, General Counsel and Secretary, Abbott Laboratories
2011 Compensation: $5,567,493
#5. Amy W. Schulman
EVP, General Counsel, President and GM, Nutrition, Pfizer
2011 Compensation: $5,764,662
#4. Beatrice Cazala
EVP Commercial Operations, Bristol-Myers Squibb
2011 Compensation: $5,941,167
#3. Naomi Kelman
Head of Novartis OTC Division, Novartis1
2011 Compensation: $6,927,529
#2. Sherilyn S. McCoy
Vice Chairman, Executive Committee, Johnson & Johnson
2011 Compensation: $8,733,678
#1. Heather Bresch
CEO, Mylan
2011 Compensation: $9,640,486
Leave a comment by clicking the “Comments” icon below. We want to hear your thoughts!
1Resigned from position in 2012.
This list includes only women employed at public companies. Compensation was obtained from publicly available figures published in the companies’ Definitive Proxy Statements (DEF 14A) and/or S-1 statements for initial public offerings. For executives paid in non-U.S. currencies, $USD figures are accurate as rounded off to the nearest dollar as of July 30, 2012.